Review the official metadata and clinical abstract via the verified DOI link below.
Tagged Adult, Belgium, Crohn Disease, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Gastrointestinal Agents, Humans, Injections, Subcutaneous, Leukocyte L1 Antigen Complex, Maintenance Chemotherapy, Male, Middle Aged, Patient Reported Outcome Measures, Prospective Studies, Remission Induction, Time Factors, Treatment Failure, Treatment Outcome, Ustekinumab, Young Adult 